Rocket Pharmaceuticals, Inc. SEC filings RCKT
Rocket Pharmaceuticals, Inc. has 968 filings in SEC EDGAR's recent list, going back to Feb 25, 2004. Its latest annual report, Form ARS, was filed on Apr 6, 2026 for the period ended Dec 31, 2025. The latest quarterly report (Form 10-Q) was filed on Aug 10, 2026, covering the quarter ended Jun 30, 2026. The most recent current report (Form 8-K) was filed on Oct 6, 2026 (material agreement, new debt, unregistered share sale, regulation fd disclosure). The company's fiscal year ends on December 31.
| Form | Description | Filed | Period |
|---|---|---|---|
| S-8 | Employee stock plan registration | Jul 14, 2026 | — |
| 424B5 | Prospectus supplement | Mar 10, 2026 | — |
| S-3 | Shelf registration | Mar 2, 2026 | — |
| S-8 | Employee stock plan registration | Mar 3, 2025 | — |
| 424B5 | Prospectus supplement | Dec 12, 2024 | — |
| 424B5 | Prospectus supplement | Dec 10, 2024 | — |
| S-3ASR | Automatic shelf registration | Aug 16, 2024 | — |
| 424B5 | Prospectus supplement | Sep 20, 2023 | — |
| 424B5 | Prospectus supplement | Sep 13, 2023 | — |
| 424B5 | Prospectus supplement | Sep 12, 2023 | — |
| POS AM | Filing | Apr 5, 2023 | — |
| S-8 | Employee stock plan registration | Dec 20, 2022 | — |
| 424B3 | Prospectus | Oct 31, 2022 | — |
| S-4/A | Filing | Oct 27, 2022 | — |
| S-4 | Registration for a merger or exchange | Oct 13, 2022 | — |
| 424B5 | Prospectus supplement | Oct 4, 2022 | — |
| 424B5 | Prospectus supplement | Oct 3, 2022 | — |
| 424B5 | Prospectus supplement | Mar 1, 2022 | — |
| S-3/A | Filing | Sep 3, 2021 | — |
| S-3/A | Filing | May 10, 2021 | — |
| S-3 | Shelf registration | Mar 2, 2021 | — |
| 424B5 | Prospectus supplement | Dec 11, 2020 | — |
| S-3MEF | Filing | Dec 9, 2020 | — |
| 424B5 | Prospectus supplement | Dec 9, 2020 | — |
| S-8 | Employee stock plan registration | Mar 6, 2020 | — |
| 424B5 | Prospectus supplement | Dec 11, 2019 | — |
| 424B5 | Prospectus supplement | Dec 10, 2019 | — |
| S-3 | Shelf registration | Jun 17, 2019 | — |
| 424B5 | Prospectus supplement | Apr 17, 2019 | — |
| 424B5 | Prospectus supplement | Apr 15, 2019 | — |
| 424B5 | Prospectus supplement | Nov 29, 2018 | — |
| FWP | Free writing prospectus | Nov 28, 2018 | — |
| 424B5 | Prospectus supplement | Nov 26, 2018 | — |
| S-3 | Shelf registration | Jun 26, 2018 | — |
| S-3ASR | Automatic shelf registration | Jun 25, 2018 | — |
| S-8 | Employee stock plan registration | Mar 7, 2018 | — |
| 424B5 | Prospectus supplement | Jan 25, 2018 | — |
| 424B5 | Prospectus supplement | Jan 23, 2018 | — |
| S-8 | Employee stock plan registration | Mar 23, 2017 | — |
| 424B5 | Prospectus supplement | Aug 3, 2016 | — |
| FWP | Free writing prospectus | Aug 2, 2016 | — |
| 424B5 | Prospectus supplement | Aug 1, 2016 | — |
| S-8 | Employee stock plan registration | Jun 29, 2016 | — |
| S-3 | Shelf registration | Apr 4, 2016 | — |
| 424B2 | Prospectus | Aug 13, 2015 | — |
| S-1MEF | Form s-1 mef | Aug 12, 2015 | — |
| S-1/A | Amended registration statement | Aug 10, 2015 | — |
| S-1 | Registration statement | Jul 31, 2015 | — |
| S-8 | Employee stock plan registration | May 28, 2015 | — |
| 424B4 | Prospectus | Feb 19, 2015 | — |
| 424B4 | Prospectus | Feb 19, 2015 | — |
| FWP | Free writing prospectus | Feb 18, 2015 | — |
| S-1/A | Amended registration statement | Feb 17, 2015 | — |
| FWP | Free writing prospectus | Feb 17, 2015 | — |
| S-1/A | Amended registration statement | Feb 17, 2015 | — |
| S-1/A | Amended registration statement | Jan 22, 2015 | — |
| S-1/A | Amended registration statement | Jan 14, 2015 | — |
| S-1/A | Amended registration statement | Nov 21, 2014 | — |
| S-1 | Registration statement | Nov 5, 2014 | — |
Showing 59 filings. Main filings leave out insider and ownership forms such as Form 4; choose a type above to see them. Each form opens on SEC.gov. Older filings are on SEC EDGAR.
New to this? Read What Are SEC Filings? 10-K, 10-Q, 8-K and Other Forms Explained.
Company profile
- Industry
- Pharmaceutical Preparations (SIC 2834)
- Listed as
- RCKT (Nasdaq)
- Fiscal year ends
- December 31
- Incorporated in
- DE
- Headquarters
- New York, NY
- SEC filer status
- Non-accelerated filer, Smaller reporting company
- SEC CIK
- 1281895
- Former names
- INOTEK PHARMACEUTICALS CORP (until Dec 22, 2017)
Other Pharmaceutical Preparations companies
- ELI LILLY & Co LLY
- Johnson & Johnson JNJ
- AbbVie Inc. ABBV
- Merck & Co., Inc. MRK
- Novartis AG NVS
- Astrazeneca PLC AZN
- Abbott Laboratories ABT
- Novo Nordisk A S NVO
Source: SEC EDGAR filings. This is company-reported data, not investment advice.